PP
MRK icon

Paloma Partners’s Merck MRK Stock Holding History

Paloma Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,600
Closed -$446K – 1488
2024
Q2 		$446K Buy
+3,600
New +$464K 0.01% 799
2023
Q3 		– Sell
-19,400
Closed -$2.24M – 863
2023
Q2 		$2.24M Sell
19,400
-1,900
-9% -$216K 0.08% 233
2023
Q1 		$2.27M Buy
+21,300
New +$2.3M 0.08% 220
2022
Q4 		– Sell
-23,900
Closed -$2.06M – 1074
2022
Q3 		$2.06M Buy
+23,900
New +$2.13M 0.09% 180
2021
Q4 		– Sell
-19,200
Closed -$1.44M – 2025
2021
Q3 		$1.44M Sell
19,200
-15,200
-44% -$1.16M 0.04% 289
2021
Q2 		$2.68M Sell
34,400
-80,775
-70% -$6.01M 0.05% 347
2021
Q1 		$8.47M Buy
+115,175
New +$8.5M 0.18% 92
2019
Q1 		– Sell
-18,130
Closed -$1.32M – 1838
2018
Q4 		$1.32M Buy
+18,130
New +$1.28M 0.04% 370
2018
Q2 		– Sell
-36,680
Closed -$1.91M – 1997
2018
Q1 		$1.91M Hold
36,680
– – 0.03% 601
2017
Q4 		$1.97M Hold
36,680
– – 0.03% 674
2017
Q3 		$2.24M Hold
36,680
– – 0.03% 659
2017
Q2 		$2.24M Sell
36,680
-1,362
-4% -$82.9K 0.03% 680
2017
Q1 		$2.31M Sell
38,042
-41,920
-52% -$2.54M 0.03% 700
2016
Q4 		$4.49M Sell
79,962
-20,646
-21% -$1.21M 0.04% 291
2016
Q3 		$5.99M Buy
100,608
+42,758
+74% +$2.5M 0.08% 159
2016
Q2 		$3.18M Sell
57,850
-20,960
-27% -$1.12M 0.04% 437
2016
Q1 		$3.98M Buy
78,810
+11,738
+18% +$575K 0.07% 243
2015
Q4 		$3.38M Sell
67,072
-4,192
-6% -$211K 0.09% 191
2015
Q3 		$3.36M Sell
71,264
-131,629
-65% -$6.99M 0.08% 192
2015
Q2 		$11M Buy
+202,893
New +$11.4M 0.21% 96

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paloma Partners's MRK Position: Q2 2025 in Review

Paloma Partners sold out of Merck (MRK) in Q2 2025, closing a stake of 5,885 shares — an estimated $528K sold.

Paloma Partners first reported a position in MRK in Q2 2013 and held it in 40 quarters. The position peaked at $29.6M in Q4 2018. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Paloma Partners reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Paloma Partners sold 5,885 Merck shares in Q2 2025, an estimated $528K.
  • Paloma Partners first reported a position in Merck in Q2 2013 and held it in 40 quarters.
  • Paloma Partners's Merck position peaked at $29.6M in Q4 2018.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.